Ikarian Capital LLC 13D and 13G filings for TRACON Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 4:10 pm Sale | 2024-03-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 133,547 5.900% | -4,730 (-3.42%) | Filing |
| 2023-02-14 12:57 pm Purchase | 2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 138,277 12.500% | 3,721 (+2.77%) | Filing |
| 2022-02-14 4:37 pm Sale | 2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 134,556 13.800% | -1,287 (-0.95%) | Filing |
| 2021-02-16 08:33 am Purchase | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 135,842 17.800% | 27,715 (+25.63%) | Filing |
| 2020-09-14 5:00 pm Purchase | 2020-09-01 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital LLC | 108,127 16.400% | 108,127 (New Position) | Filing |